|
|
(4aR)-7α-Vinyl-1,4,4a,4bβ,5,6,7,9,10,10aβ-decahydro-6α-hydroxy-1,1,7-trimethylphenanthren-3(2H)-one |
(4aR)-7α-Vinyl-1,4,4a,4bβ,5,6,7,9,10,10aβ-decahydro-6α-hydroxy-1,1,7-trimethylphenanthren-3(2H)-one |
|
|
ATAXIATELAGIECTASIAMUTATED(ATM),350KD,CLONE:ATX08,MABANTI-HUMAN,MOUSE:PARAFFIN,IH/WB |
ATAXIATELAGIECTASIAMUTATED(ATM),350KD,CLONE:ATX08,MABANTI-HUMAN,MOUSE:PARAFFIN,IH/WB |
|
|
(aS)-2'-Methoxy-N-[(1S,2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl]-1,1'-binaphthalene-2-carboxamide |
(aS)-2'-Methoxy-N-[(1S,2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl]-1,1'-binaphthalene-2-carboxamide |
|
|
(1aS)-2β,7β-Methano-1aα,2,7,7aα-tetrahydronaphtho[2,3-b]oxirene |
(1aS)-2β,7β-Methano-1aα,2,7,7aα-tetrahydronaphtho[2,3-b]oxirene |
|
|
(aS)-2'-Methoxy-N-[(1R,2S,4R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl]-1,1'-binaphthalene-2-carboxamide |
(aS)-2'-Methoxy-N-[(1R,2S,4R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl]-1,1'-binaphthalene-2-carboxamide |
|
|
(4aS)-5β-Methyl-8aβ-hydroxy-5-(4-methyl-3-pentenyl)-3,4,4aα,5,6,7,8,8a-octahydronaphthalen-1(2H)-one |
(4aS)-5β-Methyl-8aβ-hydroxy-5-(4-methyl-3-pentenyl)-3,4,4aα,5,6,7,8,8a-octahydronaphthalen-1(2H)-one |
|
|
(3aS)-2-Methyl-4,5,6,7,8,8aα-hexahydro-3aαH-cycloheptoxazole |
(3aS)-2-Methyl-4,5,6,7,8,8aα-hexahydro-3aαH-cycloheptoxazole |
|
|
|